Cognetivity Neurosciences Ltd. (CGNSF)
USD 0.0
(-94.74%)
USD 0.0
(-94.74%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 45.36 Thousand CAD | -50.71% |
| 2022 | 13.05 Million CAD | 431.29% |
| 2021 | 2.45 Million CAD | -5.68% |
| 2020 | 2.6 Million CAD | -38.14% |
| 2019 | 4.21 Million CAD | 181.96% |
| 2018 | 1.49 Million CAD | 213.33% |
| 2017 | 476.79 Thousand CAD | 726.69% |
| 2016 | 57.67 Thousand CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 915.8 Thousand CAD | -19.57% |
| 2024 Q3 | 922.21 Thousand CAD | -96.82% |
| 2024 Q1 | 1.13 Million CAD | -20.75% |
| 2023 Q4 | 1.43 Million CAD | -19.37% |
| 2023 Q3 | 1.78 Million CAD | 3.18% |
| 2023 Q2 | 1.72 Million CAD | 15.84% |
| 2023 Q1 | 1.49 Million CAD | -71.0% |
| 2023 FY | 6.43 Million CAD | -50.71% |
| 2022 Q2 | 1.09 Million CAD | 8.0% |
| 2022 FY | 13.05 Million CAD | 431.29% |
| 2022 Q4 | 5.13 Million CAD | -11.76% |
| 2022 Q1 | 1.01 Million CAD | 1.27% |
| 2022 Q3 | 5.82 Million CAD | 429.65% |
| 2021 FY | 2.45 Million CAD | -5.68% |
| 2021 Q4 | 1 Million CAD | 47.95% |
| 2021 Q3 | 679.59 Thousand CAD | 6.71% |
| 2021 Q2 | 636.84 Thousand CAD | 326.39% |
| 2021 Q1 | 149.35 Thousand CAD | -53.0% |
| 2020 Q4 | 317.79 Thousand CAD | -56.52% |
| 2020 Q1 | 767.29 Thousand CAD | -16.96% |
| 2020 Q2 | 789.58 Thousand CAD | 2.9% |
| 2020 FY | 2.6 Million CAD | -38.14% |
| 2020 Q3 | 730.9 Thousand CAD | -7.43% |
| 2019 Q4 | 924.05 Thousand CAD | -4.59% |
| 2019 FY | 4.21 Million CAD | 181.96% |
| 2019 Q3 | 968.54 Thousand CAD | 45.39% |
| 2019 Q2 | 666.15 Thousand CAD | -59.71% |
| 2019 Q1 | 1.65 Million CAD | 55.38% |
| 2018 Q2 | 169.72 Thousand CAD | 98.42% |
| 2018 FY | 1.49 Million CAD | 213.33% |
| 2018 Q3 | 174.46 Thousand CAD | 2.79% |
| 2018 Q4 | 1.06 Million CAD | 510.01% |
| 2018 Q1 | 85.54 Thousand CAD | -27.53% |
| 2017 Q3 | 101.17 Thousand CAD | 0.0% |
| 2017 Q4 | 118.03 Thousand CAD | 16.66% |
| 2017 FY | 476.79 Thousand CAD | 726.69% |
| 2016 FY | 57.67 Thousand CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Achiko AG | 6.78 Million USD | 99.331% |
| Accelera Innovations, Inc | - USD | -Infinity% |
| Aspyra Inc. | 8.04 Million USD | 99.436% |
| Cannabis Sativa, Inc. | 862.24 Thousand USD | 94.739% |
| CompuMed, Inc. | 2.91 Million USD | 98.445% |
| CompuGroup Medical SE & Co. KGaA | 1 Billion USD | 99.995% |
| Cogstate Limited | 23.64 Million USD | 99.808% |
| CareView Communications, Inc. | 7.21 Million USD | 99.372% |
| Craneware plc | 141.35 Million USD | 99.968% |
| Caduceus Software Systems Corp. | 2.07 Million USD | 97.818% |
| Certive Solutions Inc. | 1.5 Million USD | 96.993% |
| Drug Free Solution, Inc. | 1.39 Million USD | 96.75% |
| DATATRAK International, Inc. | 3.26 Million USD | 98.612% |
| Strainsforpains, Inc. | 149.72 Thousand USD | 69.7% |
| Healixa Inc. | 6.56 Million USD | 99.309% |
| Easy Technologies Inc. | - USD | -Infinity% |
| eWellness Healthcare Corporation | - USD | -Infinity% |
| Founders Bay Holdings | 3.28 Million USD | 98.617% |
| Health Discovery Corporation | - USD | -Infinity% |
| Healthcare Integrated Technologies, Inc. | 702.92 Thousand USD | 93.546% |
| H-Source Holdings Ltd. | - USD | -Infinity% |
| InterCare DX, Inc. | 491.28 USD | -9134.245% |
| IQ-AI Limited | 1.13 Million USD | 95.99% |
| Cannabiz Mobile, Inc. | 750.00 USD | -5948.8% |
| Mednow Inc. | 2.78 Million USD | 98.37% |
| Galileo Life Sciences, Inc. | 270.72 Thousand USD | 83.243% |
| MediXall Group, Inc. | 59.26 Thousand USD | 23.456% |
| Mitesco, Inc. | 2.58 Million USD | 98.246% |
| MobileSmith, Inc. | 8.63 Million USD | 99.475% |
| NantHealth, Inc. | 94.47 Million USD | 99.952% |
| Net Medical Xpress Solutions, Inc. | 1.76 Million USD | 97.424% |
| OneLife Technologies Corp. | - USD | -Infinity% |
| ORHub, Inc. | 12.38 Million USD | 99.634% |
| Patient Access Solutions, Inc. | 9.19 Million USD | 99.507% |
| Pharma-Bio Serv, Inc. | 3.94 Million USD | 98.851% |
| PPJ Healthcare Enterprises, Inc. | 141.33 Thousand USD | 67.902% |
| Medical Cannabis Payment Solutions, Inc. | 12.18 Thousand USD | -272.341% |
| Renalytix Plc | 29.04 Million USD | 99.844% |
| Revium Recovery Inc. | 677 Thousand USD | 93.299% |
| RYAH Group, Inc. | - USD | -Infinity% |
| Carepay Inc. | 369.00 USD | -12194.309% |
| Vaso Corporation | 46.39 Million USD | 99.902% |
| Vynleads, Inc. | 200.15 Thousand USD | 77.335% |